Monica Desai

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

Sheena McCormack, David Dunn, Monica Desai et al. · The Lancet · 2015 · 1.9K citations · Full text

Public Health, Pharmacotherapy, Preventive Medicine +14

Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial

Katrina M. Pollock, Hannah M. Cheeseman, Alexander J. Szubert et al. · EClinicalMedicine · 2022 · 162 citations · Full text

Pharmacy, Biotechnology, Immunology +16

Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation

Valentina Cambiano, Alec Miners, David Dunn et al. · The Lancet Infectious Diseases · 2017 · 120 citations · Full text

Pharmacy, Pharmacoeconomics, Preventive Medicine +17

BHIVA/BASHH guidelines on the use of HIV pre–exposure prophylaxis (PrEP) 2018

Michael Brady, Alison Rodger, David Asboe et al. · HIV Medicine · 2019 · 94 citations · Full text

Public Health, Community Health, Preventive Medicine +17

Healthcare providers' knowledge of, attitudes to and practice of pre‐exposure prophylaxis for <scp>HIV</scp> infection

Monica Desai, Mitzy Gafos, David Dolling et al. · HIV Medicine · 2015 · 67 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +17